Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/15/2025

Testosterone Level Evaluation and Treatment Guidelines

Diagnostic Criteria and Treatment Indications

  • The American Urological Association recommends that a diagnostic threshold for testosterone deficiency is <300 ng/dL on two separate morning measurements, not 455 ng/dL 1, 3, 4
  • The European Association of Urology and International consensus guidelines, including the Princeton III Consensus, agree that testosterone >350 ng/dL typically does not require replacement therapy 2
  • Treatment should only be initiated in men with both biochemically confirmed low testosterone (<300 ng/dL) AND clinical symptoms of hypogonadism, as recommended by the American Urological Association and European Association of Urology 1, 3, 4
  • A level of 455 ng/dL represents the middle tertile of the normal reference range (450-600 ng/dL), which is the exact target that clinicians aim for when treating men with true testosterone deficiency, according to the American Urological Association 1, 2

Critical Diagnostic Requirements

  • Two separate morning measurements (8-10 AM) showing levels <300 ng/dL are required for diagnosis, as stated by the European Association of Urology 3, 4
  • Clinical symptoms must be present, including reduced libido, erectile dysfunction, decreased energy, fatigue, reduced muscle mass, or depressed mood, as recommended by the American Urological Association and European Association of Urology 3, 4
  • The American Urological Association and European Association of Urology explicitly recommend against initiating testosterone therapy in eugonadal individuals (those with normal testosterone levels) 2

Safety Considerations

  • Exogenous testosterone suppresses spermatogenesis and should not be used in men trying to conceive, as warned by the American Urological Association 1
  • Testosterone therapy carries potential cardiovascular risks, and should not be commenced within 3-6 months of cardiovascular events, according to the American Urological Association 1
  • Monitoring for erythrocytosis, prostate health, and cardiovascular symptoms is mandatory during treatment, as recommended by the American Urological Association 1

Prevalence of Inappropriate Prescribing

  • Approximately 20-25% of men receiving testosterone therapy do not meet diagnostic criteria for testosterone deficiency, highlighting widespread inappropriate prescribing, as reported by the American Urological Association 2, 4
  • Nearly half of men placed on testosterone therapy do not have their testosterone levels checked after therapy commences, leading to potential over- or under-dosing, according to the American Urological Association 2

Alternative Approaches

  • Consider lifestyle modifications first: weight loss, increased physical activity, and addressing obesity can improve testosterone levels and symptoms, as recommended by the American Urological Association 1
  • Evaluate for other causes of symptoms: fatigue, low libido, and erectile dysfunction have multiple etiologies beyond testosterone deficiency, as stated by the European Association of Urology
  • Repeat testing only if clinically indicated: if symptoms persist and there's genuine clinical suspicion, repeat two morning testosterone measurements, as recommended by the European Association of Urology 3, 4

REFERENCES

2

Testosterone Testing and Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Testosterone Deficiency Diagnosis and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Target Testosterone Level in Testosterone Replacement Therapy (TRT) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025